Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel L Moschella

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of the American Academy of Dermatology|September 1, 2004
An update on the diagnosis and treatment of leprosySamuel L Moschella
International Journal of Dermatology|January 5, 2008
Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated casesSamuel L Moschella
Skinmed|January 18, 2005
Is there a role for tumor necrosis factor-alpha inhibitors and especially thalidomide in dermatology?Samuel L Moschella
JAMA Dermatology|February 15, 2017
The Role of Rifampin in Leprosy : Leprosy Through a New LensHerbert B Allen, Samuel L Moschella
Journal of Cutaneous Pathology|May 21, 2010
Global dermatopathology: Hansen's disease--current concepts and challengesAdriano Piris, Alice Z C Lobo, Samuel L Moschella
Clinics in Dermatology|November 23, 2006
Neutrophilic dermatosesArturo P Saavedra, Susanne Christine Kovacs, Samuel L Moschella
The New England Journal of Medicine|November 19, 2004
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 35-2004. A 68-year-old man with end-stage renal disease and thickening of the skinSamuel L Moschella, Jonathan Kay, Bonnie T Mackool, et al.
Journal of the American Academy of Dermatology|April 26, 2006
Clinical and pathologic findings of paraneoplastic dermatosesVinh Q Chung, Samuel L Moschella, Artur Zembowicz, et al.
Cutis|September 5, 2003
Cutaneous mucormycosis secondary to acquired reactive perforating collagenosisStefan C Weiss, Samuel L Moschella, Theodore Kwan, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2011
Part III: cutaneous hypersensitivity during selective serotonin reuptake inhibitor therapy resulting in acquired cutis laxaJennifer K Tan, Adam D Lipworth, Andrew A Nelson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of the American Academy of Dermatology|September 1, 2004
An update on the diagnosis and treatment of leprosySamuel L Moschella
International Journal of Dermatology|January 5, 2008
Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated casesSamuel L Moschella
Skinmed|January 18, 2005
Is there a role for tumor necrosis factor-alpha inhibitors and especially thalidomide in dermatology?Samuel L Moschella
JAMA Dermatology|February 15, 2017
The Role of Rifampin in Leprosy : Leprosy Through a New LensHerbert B Allen, Samuel L Moschella
Journal of Cutaneous Pathology|May 21, 2010
Global dermatopathology: Hansen's disease--current concepts and challengesAdriano Piris, Alice Z C Lobo, Samuel L Moschella
Clinics in Dermatology|November 23, 2006
Neutrophilic dermatosesArturo P Saavedra, Susanne Christine Kovacs, Samuel L Moschella
The New England Journal of Medicine|November 19, 2004
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 35-2004. A 68-year-old man with end-stage renal disease and thickening of the skinSamuel L Moschella, Jonathan Kay, Bonnie T Mackool, et al.
Journal of the American Academy of Dermatology|April 26, 2006
Clinical and pathologic findings of paraneoplastic dermatosesVinh Q Chung, Samuel L Moschella, Artur Zembowicz, et al.
Cutis|September 5, 2003
Cutaneous mucormycosis secondary to acquired reactive perforating collagenosisStefan C Weiss, Samuel L Moschella, Theodore Kwan, et al.
Journal of Drugs in Dermatology : JDD|February 2, 2011
Part III: cutaneous hypersensitivity during selective serotonin reuptake inhibitor therapy resulting in acquired cutis laxaJennifer K Tan, Adam D Lipworth, Andrew A Nelson, et al.
Pageof 2